Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6015561 | 0.77 | ALDH1A1 (0.42) | ALDH1A1POLBHPGDGAAABL1 | |
| SCHEMBL6015562 | 0.74 | ALDH1A1 (0.40) | ALDH1A1POLBHPGDMEN1KMT2A | |
| SCHEMBL6015600 | 0.71 | POLB (0.41) | ALDH1A1POLBHPGDMEN1KMT2A | |
| SCHEMBL1621745 | 0.71 | ALDH1A1 (0.50) | ALDH1A1POLBHPGDMEN1KMT2A | |
| SCHEMBL22644428 | 0.66 | ALDH1A1 (0.37) | ALDH1A1HPGDGAAIDO1 | |
| SCHEMBL13757223 | 0.66 | IDO1 (0.50) | ALDH1A1POLBHPGDGAAABL1 | |
| SCHEMBL10604745 | 0.65 | CCNA2 (0.34) | — | |
| SCHEMBL1622881 | 0.64 | ABCB1 (0.56) | SMN1; SMN2L3MBTL1GAA | |
| SCHEMBL10447738 | 0.62 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1 | |
| SCHEMBL3187771 | 0.61 | MEN1 (0.31) | POLBMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012054526-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ELCELYX THERAPEUTICS, INC. (US) | 2012-04-26 | — | — | WO | disclosed |